SecSonar.com

Absci Corporation (ABSI)

Absci Corporation at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Absci Corporation (ABSI) is a Biotechnology company based in US with a market capitalization of $1.1B. Revenue declined 38.2% year-over-year and free cash flow was negative at -$94M. This page tracks ABSI's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 156 employees · IPO Jul 22, 2021

Valuation

Valuation & price

$5.54 · as of May 15, 2026 · -52.3% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

5.95

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$11.62$6.96$2.30Jul 25Dec 25Jul 26Jul 7, 25$2.58Jul 9, 25$2.83Jul 11, 25$2.67Jul 15, 25$2.57Jul 17, 25$2.88Jul 21, 25$3.51Jul 23, 25$3.52Jul 25, 25$2.89Jul 29, 25$2.95Jul 31, 25$2.83Aug 4, 25$2.99Aug 6, 25$2.91Aug 11, 25$2.85Aug 13, 25$3.12Aug 15, 25$2.93Aug 19, 25$2.62Aug 21, 25$2.56Aug 25, 25$2.54Aug 27, 25$2.55Aug 29, 25$2.39Sep 3, 25$2.38Sep 5, 25$2.46Sep 9, 25$2.54Sep 11, 25$2.74Sep 16, 25$2.70Sep 18, 25$2.69Sep 22, 25$2.69Sep 24, 25$2.49Sep 26, 25$2.73Sep 30, 25$3.04Oct 2, 25$3.55Oct 6, 25$3.76Oct 8, 25$4.18Oct 10, 25$3.68Oct 14, 25$3.90Oct 16, 25$4.87Oct 21, 25$4.61Oct 23, 25$4.28Oct 27, 25$4.50Oct 29, 25$4.37Oct 31, 25$4.28Nov 4, 25$3.94Nov 6, 25$3.59Nov 10, 25$3.32Nov 12, 25$3.40Nov 14, 25$2.82Nov 18, 25$2.84Nov 20, 25$2.77Nov 25, 25$3.07Nov 28, 25$3.17Dec 2, 25$3.03Dec 4, 25$3.73Dec 8, 25$3.45Dec 10, 25$3.97Dec 12, 25$3.64Dec 16, 25$3.55Dec 18, 25$3.41Dec 22, 25$3.67Dec 24, 25$3.56Dec 29, 25$3.45Jan 2, 26$3.61Jan 6, 26$3.90Jan 8, 26$3.44Jan 12, 26$3.40Jan 14, 26$3.35Jan 16, 26$3.02Jan 21, 26$3.02Jan 23, 26$2.91Jan 27, 26$2.98Jan 29, 26$3.03Feb 2, 26$3.02Feb 4, 26$2.91Feb 9, 26$2.76Feb 11, 26$2.60Feb 13, 26$2.55Feb 18, 26$2.70Feb 20, 26$2.65Feb 24, 26$2.71Feb 26, 26$2.81Mar 2, 26$2.80Mar 4, 26$2.66Mar 6, 26$2.38Mar 10, 26$2.54Mar 12, 26$2.30Mar 17, 26$3.03Mar 19, 26$3.08Mar 23, 26$2.93Mar 25, 26$2.92Mar 27, 26$2.78Mar 31, 26$3.00Apr 2, 26$3.06Apr 7, 26$2.92Apr 9, 26$2.95Apr 13, 26$3.05Apr 15, 26$3.17Apr 17, 26$3.58Apr 22, 26$3.68Apr 24, 26$3.94Apr 28, 26$4.86Apr 30, 26$4.97May 4, 26$5.62May 6, 26$5.95May 8, 26$5.90May 12, 26$5.36May 14, 26$5.54May 18, 26$4.95May 20, 26$4.95May 22, 26$5.10May 28, 26$6.08Jun 1, 26$6.52Jun 3, 26$5.94Jun 5, 26$6.40Jun 9, 26$6.83Jun 11, 26$6.51Jun 15, 26$7.27Jun 17, 26$7.18Jun 22, 26$8.40Jun 24, 26$10.07Jun 26, 26$10.89Jul 2, 26$11.62
$2.3052-week range$11.62
Loading valuation history…

Fundamentals

Key fundamentals

$1.1B

Market cap

-38.2%

Revenue growth (YoY)

-319.4%

Gross margin

-$94M

Free cash flow (USD)

-$139M

Net debt

Net cash position

24.1%

Share dilution

2/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2019 → 2025

FY 2019$2.1MFY 2020$4.8MFY 2021$4.8MFY 2022$5.7MFY 2023$5.7MFY 2024$4.5MFY 2025$2.8M
$2.1M$2.8M

Free cash flow by year

2019 → 2025

FY 2019$-7.1MFY 2020$-13.2MFY 2021$-98.6MFY 2022$-97.5MFY 2023$-65.5MFY 2024$-72.8MFY 2025$-94.0M
-$7.1M-$94M

Gross margin by year

2021 → 2025

FY 2021-832.4%FY 2022-925.0%FY 2023-731.9%FY 2024-1277.6%FY 2025-319.4%
-832.4%-319.4%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

1

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 7, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventCommon Stock OfferingJun 24, 2026Filing
  • 8-K eventInterim Data AnnouncementJun 24, 2026Filing
  • 8-K eventAnnual Meeting ResultsJun 5, 2026Filing
  • Insider buyInsider Buy $201KPangalos Menelas N · Director · $200.7KMay 13, 2026Filing
  • 8-K eventEarnings ReleaseMay 7, 2026Filing
  • Quarterly report10-Q FiledMay 7, 2026Filing

Questions

Frequently asked questions

What is Absci Corporation's market cap?

Absci Corporation (ABSI) has a market capitalization of $1.1B.

What is ABSI's P/E ratio?

A meaningful P/E ratio is not available for ABSI — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is ABSI's price-to-book (P/B) ratio?

ABSI trades at 5.95 times book value per share.

Are insiders buying ABSI stock?

Yes — SEC Form 4 filings show 1 open-market insider buy and 0 sells at Absci Corporation in the last 90 days.

Same arena

Related companies in Biotechnology

OPK

OPKO Health, Inc.

$1.1B

EYPT

EyePoint Pharmaceuticals, Inc.

$1.2B

AKTS

Aktis Oncology, Inc.

$1.1B

AMLX

Amylyx Pharmaceuticals, Inc.

$1.2B

MNKD

MannKind Corporation

$1.2B

XERS

Xeris Biopharma Holdings, Inc.

$1.1B

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.